Vol 57, No 4s (2005)

Published: 2005-12-30

Articles

Are there differences among anti-TNFa biological drugs?

G. Valesini
DOI https://doi.org/10.4081/reumatismo.2005.4s.1

Pages 1-2

PDF

Effects of TNF antagonists on immune and neuroendocrine system

G. Valesini, M. Cutolo
DOI https://doi.org/10.4081/reumatismo.2005.4s.3

Pages 3-7

PDF

Differences in pharmacology of tumor necrosis factor (TNF) antagonists

U. Fiocco, S. Bombardieri
DOI https://doi.org/10.4081/reumatismo.2005.4s.8

Pages 8-16

PDF

Biologic therapy with anti-TNFa in rheumathoid atrhritis

G. Ferraccioli
DOI https://doi.org/10.4081/reumatismo.2005.4s.17

Pages 17-21

PDF

Biologic therapy with anti-TNFa in spondyloarthritides and other autoimmune diseases

G. Lapadula
DOI https://doi.org/10.4081/reumatismo.2005.4s.22

Pages 22-29

PDF

Approved indications and other possible utilizations of anti-TNFa biologic drugs

W. Grassi, C. Montecucco
DOI https://doi.org/10.4081/reumatismo.2005.4s.30

Pages 30-33

PDF

Safety of anti-TNFa biological drugs

F. Trotta, G. Valentini
DOI https://doi.org/10.4081/reumatismo.2005.4s.34

Pages 34-39

PDF